Matt Mixick
Analyst
Barclays
Equibles does not estimate personal net worth.
About Matt Mixick
Matt Mixick is recorded as Analyst at Barclays. Matt Mixick has spoken on 15 earnings calls across 13 companies, most recently for Humacyte, Inc. on May 13, 2026. Those appearances were for Senseonics Holdings, Inc. (SENS), Humacyte, Inc. (HUMA), Globus Medical Inc (GMED), Alcon Inc (ALC), InMode Ltd. (INMD) and 8 other companies. The companies whose calls Matt Mixick spoke on are classified in the Healthcare sector.
Matt Mixick on recent calls
“And so I wanted to ask about the commercial efforts that you're putting in place to sort of drive greater adoption in the, I guess, the U.S. market for trauma, away from some of the government contracts that you've established, which are great.”
“I was wondering about just robot demand, you know, hospital investments and robot platforms.”
“You know, I had one question on just sort of like the retention of some of the folks using the system, and then one on sort of the next-gen technology platform power enhancements that you've made.”
“So, listen, I appreciate the color on the market, and congrats on the progress on PanObjects Pro.”
“So on ophthalmology, I was wondering if you could, and I've been hopping around here between calls, so apologies if it's already been covered, but maybe an update on, you know, how the U.S. sales reorg and management is driving that growth, what your plans are there, maybe what some of the early results you've seen…”
Affiliation history
-
Barclays
Analyst
Transcript header (unverified)
Current
Company network
HUMA
Biotechnology · Healthcare
GMED
Medical Devices · Healthcare
ALC
Medical Instruments & Supplies · Healthcare
INMD
Medical Devices · Healthcare
SYK
Medical Devices · Healthcare
Drug Manufacturers - General · Healthcare
BLCO
Medical Instruments & Supplies · Healthcare
DXCM
Medical Devices · Healthcare
Medical Instruments & Supplies · Healthcare